ABCL

Latest SEC Filings & News for ABCL

2 most recent filings and news items mentioning ABCL. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/ABCL/news?limit=20"

Pull ABCL filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
M&AJun 17, 2026Positive

Jazz Pharmaceuticals and AbCellera partner on T-cell antibody discovery

Jazz Pharmaceuticals and AbCellera announced a collaboration to discover next-generation T-cell engaging multispeci​fic antibodies, with Jazz paying $56 million upfront and eligible for up to $792 million in milestone payments per program. The partnership expands Jazz's oncology

View filing at SEC.gov →
LeadershipJun 5, 2026Positive

AbCellera appoints Dr. Victor Sandor as independent board director

AbCellera appointed Dr. Victor Sandor, an experienced medical oncologist and former CMO at Array BioPharma, to its Board of Directors. The appointment strengthens the company's leadership as it advances its antibody discovery pipeline toward clinical outcomes.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.